Mark Slee

Flinders Drive
Adelaide, SA 5042, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 107 publications

Causal effects of multiple sclerosis therapies in left-truncated registry data.

Causal effects of multiple sclerosis therapies in left-truncated registry data.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 21, 2026

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: January 13, 2026

Menopause Impact on Multiple Sclerosis Disability Progression.

Menopause Impact on Multiple Sclerosis Disability Progression.

Journal: JAMA neurology
Published: September 29, 2025

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.

Journal: CNS drugs
Published: September 04, 2025

Functional Neurologic Symptoms in Multiple Sclerosis: Estimated Prevalence and Associated Comorbidities.

Functional Neurologic Symptoms in Multiple Sclerosis: Estimated Prevalence and Associated Comorbidities.

Journal: Neurology. Clinical practice
Published: July 08, 2025

Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis.

Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis.

Journal: JAMA neurology
Published: April 14, 2025

Protocol for the TMaC Study: A Patient-Blinded, Randomised, Sham-Controlled, Parallel-Group Study Evaluating Effects of Repetitive Transcranial Magnetic Stimulation on Chronic Chemotherapy-Induced Pain in Bowel Cancer Patients.

Protocol for the TMaC Study: A Patient-Blinded, Randomised, Sham-Controlled, Parallel-Group Study Evaluating Effects of Repetitive Transcranial Magnetic Stimulation on Chronic Chemotherapy-Induced Pain in Bowel Cancer Patients.

Journal: Biomedicine hub
Published: April 10, 2025

Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 2.

Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 2.

Journal: The Medical journal of Australia
Published: October 09, 2024

First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis.

First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: September 04, 2024

Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis.

Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 01, 2024

Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 1.

Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 1.

Journal: The Medical journal of Australia
Published: April 25, 2024

Prognostic significance of paramagnetic rim lesions in multiple sclerosis: A systematic review.

Prognostic significance of paramagnetic rim lesions in multiple sclerosis: A systematic review.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: March 16, 2024
Showing 1-12 of 107

Last Updated: 09/26/2026